Hormone Research in Paediatrics · 2005 · 54 citations · 32 references
MedicineEndocrinologyPediatricsChild PsychiatryDevelopmental PediatricsPediatric EndocrinologyAttention-deficit/hyperactivity DisorderChild GrowthGrowth DisordersGrowth HormoneNeurodevelopmental DisordersThyroid DisordersAdhd TreatmentChildhood AdhdMethylphenidate TherapyPediatric Stimulant MedicationsPrepubertal Growth PatternsThyroid Function EvaluationThyroid Function TestingThyroid Function Tests
OBJECTIVE: To investigate if there are any disease-related or methylphenidate-induced aberrations in growth parameters, growth hormone insulin-like growth factor (IGF)-I, IGFBP-3 axis and the thyroid function tests in children with attention deficit hyperactivity disorder (ADHD). METHODS: Newly diagnosed and untreated prepubertal children with ADHD were longitudinally followed before and approximately every 4 months after methylphenidate treatment for up to 16 months. Height SDS, weight SDS, BMI SDS, serum GH, IGF-I, IGFBP-3, T4, free T4, T3, and TSH were measured at each visit. RESULTS: All of the examined parameters were within normal limits for age before treatment. Methylphenidate treatment did not significantly affect SDS of height, weight, BMI, IGF-I and IGFBP-3 in the long run. Serum T4 and free T4 levels showed modest reductions within normal limits in a time-dependent manner. CONCLUSIONS: Prepubertal children with ADHD had normal height, weight, BMI, serum IGF-I and IGFBP-3 and thyroid functions. Methylphenidate treatment had no sustained effects on growth parameters, IGF-I and IGFBP-3 during the follow-up period of this study. However, it caused a mild decrease in total and free T4 which may warrant further monitoring.
32
Establishing a standard definition for child overweight and obesity worldwide: international survey
Tim Cole · BMJ · 2000 · 16.5K citations · Full text
Medicine, Child Health, Pediatrics +16